Evidence map›Paper›PMID 42598854›Full record

ArticleNucleic acids research2026

23S rRNA modifications stimulate catalytic activity and prevent the formation of alternative structures.

Daniel S D Larsson, Aivar Liiv, Rya Ero, Jaanus Remme, Maria Selmer

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daniel S D LarssonDepartment of Cell and Molecular Biology, Uppsala University, BMC, P.O. Box 596, SE-75124 Uppsala, Sweden.ORCID 0000-0001-7683-6419
Aivar LiivInstitute of Molecular and Cell Biology, Riia 23, University of Tartu, 51010 Tartu, Estonia.
Rya EroInstitute of Molecular and Cell Biology, Riia 23, University of Tartu, 51010 Tartu, Estonia.
Jaanus RemmeInstitute of Molecular and Cell Biology, Riia 23, University of Tartu, 51010 Tartu, Estonia.
Maria SelmerDepartment of Cell and Molecular Biology, Uppsala University, BMC, P.O. Box 596, SE-75124 Uppsala, Sweden.ORCID 0000-0001-9079-2774

Funding

Estonian Ministry of Education and Research PUT PRG1179Swedish Research Council 2016-06264Swedish Research Council 2017-03827Swedish Research Council 2022-04511Uppsala University
6 · The paper itself

Abstract

Ribosomal RNA (rRNA) modifications cluster around the peptidyl transferase centre (PTC), the catalytic centre of the ribosome, yet their collective functional roles remain unclear. Here we analyse Escherichia coli ribosomes lacking 11 or 12 modifications near the PTC. Using kinetic assays, we show these hypo-modified ribosomes catalyse peptide bond formation at rates twofold to threefold lower than wild-type and exhibit reduced thermal stability. Cryo-electron microscopy of hypo-modified ribosomes reveals multiple alternative conformations of the PTC and exit tunnel regions, disrupting native stacking and hydrogen bonding critical for positioning of transfer RNA substrates. These findings indicate that rRNA modifications stabilize the native PTC structure, preventing formation of alternative, nonfunctional conformations and thereby enhancing catalytic efficiency. Our study provides insight into how rRNA modifications fine-tune ribosome function by maintaining structural integrity essential for efficient translation.

Indexed as

RibosomesRNA Processing, Post-TranscriptionalRNA, Ribosomal, 23SCryoelectron MicroscopyEscherichia coliKineticsModels, MolecularNucleic Acid ConformationPeptidyl TransferasesProtein BiosynthesisPeptidyl TransferasesRNA, Ribosomal, 23S

Identifiers

PMID42598854
PMCPMC13469067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.